Remission Clinic in Proteinuric Chronic Nephropathies

NCT02721342 · clinicaltrials.gov ↗

UNKNOWN

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: Ramipril, Irbesartan and Atorvastin

Sponsor

Mario Negri Institute for Pharmacological Research